Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor

Standard

Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor. / Rühl, Geraldine; Niedl, Anna G; Patronov, Atanas; Siewert, Katherina; Pinkert, Stefan; Kalemanov, Maria; Friese, Manuel A; Attfield, Kathrine E; Antes, Iris; Hohlfeld, Reinhard; Dornmair, Klaus.

in: NEUROL-NEUROIMMUNOL, Jahrgang 3, Nr. 4, 17.05.2016, S. e241.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Rühl, G, Niedl, AG, Patronov, A, Siewert, K, Pinkert, S, Kalemanov, M, Friese, MA, Attfield, KE, Antes, I, Hohlfeld, R & Dornmair, K 2016, 'Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor', NEUROL-NEUROIMMUNOL, Jg. 3, Nr. 4, S. e241. https://doi.org/10.1212/NXI.0000000000000241

APA

Rühl, G., Niedl, A. G., Patronov, A., Siewert, K., Pinkert, S., Kalemanov, M., Friese, M. A., Attfield, K. E., Antes, I., Hohlfeld, R., & Dornmair, K. (2016). Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor. NEUROL-NEUROIMMUNOL, 3(4), e241. https://doi.org/10.1212/NXI.0000000000000241

Vancouver

Bibtex

@article{f1fcdc8ae64e4344805b18a68f4cd69e,
title = "Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor",
abstract = "OBJECTIVE: To identify target antigens presented by human leukocyte antigen (HLA)-A*02:01 to the myelin-reactive human T-cell receptor (TCR) 2D1, which was originally isolated from a CD8+ T-cell clone recognizing proteolipid protein (PLP) in the context of HLA-A*03:01, we employed a new antigen search technology.METHODS: We used our recently developed antigen search technology that employs plasmid-encoded combinatorial peptide libraries and a highly sensitive single cell detection system to identify endogenous candidate peptides of mice and human origin. We validated candidate antigens by independent T-cell assays using synthetic peptides and refolded HLA:peptide complexes. A molecular model of HLA-A*02:01:peptide complexes was obtained by molecular dynamics simulations.RESULTS: We identified one peptide from glycerolphosphatidylcholine phosphodiesterase 1, which is identical in mice and humans and originates from a protein that is expressed in many cell types. When bound to HLA-A*02:01, this peptide cross-stimulates the PLP-reactive HLA-A3-restricted TCR 2D1. Investigation of molecular details revealed that the peptide length plays a crucial role in its capacity to bind HLA-A*02:01 and to activate TCR 2D1. Molecular modeling illustrated the 3D structures of activating HLA:peptide complexes.CONCLUSIONS: Our results show that our antigen search technology allows us to identify new candidate antigens of a presumably pathogenic, autoreactive, human CD8+ T-cell-derived TCR. They further illustrate how this TCR, which recognizes a myelin peptide bound to HLA-A*03:01, may cross-react with an unrelated peptide presented by the protective HLA class I allele HLA-A*02:01.",
author = "Geraldine R{\"u}hl and Niedl, {Anna G} and Atanas Patronov and Katherina Siewert and Stefan Pinkert and Maria Kalemanov and Friese, {Manuel A} and Attfield, {Kathrine E} and Iris Antes and Reinhard Hohlfeld and Klaus Dornmair",
year = "2016",
month = may,
day = "17",
doi = "10.1212/NXI.0000000000000241",
language = "English",
volume = "3",
pages = "e241",
journal = "NEUROL-NEUROIMMUNOL",
issn = "2332-7812",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

RIS

TY - JOUR

T1 - Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor

AU - Rühl, Geraldine

AU - Niedl, Anna G

AU - Patronov, Atanas

AU - Siewert, Katherina

AU - Pinkert, Stefan

AU - Kalemanov, Maria

AU - Friese, Manuel A

AU - Attfield, Kathrine E

AU - Antes, Iris

AU - Hohlfeld, Reinhard

AU - Dornmair, Klaus

PY - 2016/5/17

Y1 - 2016/5/17

N2 - OBJECTIVE: To identify target antigens presented by human leukocyte antigen (HLA)-A*02:01 to the myelin-reactive human T-cell receptor (TCR) 2D1, which was originally isolated from a CD8+ T-cell clone recognizing proteolipid protein (PLP) in the context of HLA-A*03:01, we employed a new antigen search technology.METHODS: We used our recently developed antigen search technology that employs plasmid-encoded combinatorial peptide libraries and a highly sensitive single cell detection system to identify endogenous candidate peptides of mice and human origin. We validated candidate antigens by independent T-cell assays using synthetic peptides and refolded HLA:peptide complexes. A molecular model of HLA-A*02:01:peptide complexes was obtained by molecular dynamics simulations.RESULTS: We identified one peptide from glycerolphosphatidylcholine phosphodiesterase 1, which is identical in mice and humans and originates from a protein that is expressed in many cell types. When bound to HLA-A*02:01, this peptide cross-stimulates the PLP-reactive HLA-A3-restricted TCR 2D1. Investigation of molecular details revealed that the peptide length plays a crucial role in its capacity to bind HLA-A*02:01 and to activate TCR 2D1. Molecular modeling illustrated the 3D structures of activating HLA:peptide complexes.CONCLUSIONS: Our results show that our antigen search technology allows us to identify new candidate antigens of a presumably pathogenic, autoreactive, human CD8+ T-cell-derived TCR. They further illustrate how this TCR, which recognizes a myelin peptide bound to HLA-A*03:01, may cross-react with an unrelated peptide presented by the protective HLA class I allele HLA-A*02:01.

AB - OBJECTIVE: To identify target antigens presented by human leukocyte antigen (HLA)-A*02:01 to the myelin-reactive human T-cell receptor (TCR) 2D1, which was originally isolated from a CD8+ T-cell clone recognizing proteolipid protein (PLP) in the context of HLA-A*03:01, we employed a new antigen search technology.METHODS: We used our recently developed antigen search technology that employs plasmid-encoded combinatorial peptide libraries and a highly sensitive single cell detection system to identify endogenous candidate peptides of mice and human origin. We validated candidate antigens by independent T-cell assays using synthetic peptides and refolded HLA:peptide complexes. A molecular model of HLA-A*02:01:peptide complexes was obtained by molecular dynamics simulations.RESULTS: We identified one peptide from glycerolphosphatidylcholine phosphodiesterase 1, which is identical in mice and humans and originates from a protein that is expressed in many cell types. When bound to HLA-A*02:01, this peptide cross-stimulates the PLP-reactive HLA-A3-restricted TCR 2D1. Investigation of molecular details revealed that the peptide length plays a crucial role in its capacity to bind HLA-A*02:01 and to activate TCR 2D1. Molecular modeling illustrated the 3D structures of activating HLA:peptide complexes.CONCLUSIONS: Our results show that our antigen search technology allows us to identify new candidate antigens of a presumably pathogenic, autoreactive, human CD8+ T-cell-derived TCR. They further illustrate how this TCR, which recognizes a myelin peptide bound to HLA-A*03:01, may cross-react with an unrelated peptide presented by the protective HLA class I allele HLA-A*02:01.

U2 - 10.1212/NXI.0000000000000241

DO - 10.1212/NXI.0000000000000241

M3 - SCORING: Journal article

C2 - 27231714

VL - 3

SP - e241

JO - NEUROL-NEUROIMMUNOL

JF - NEUROL-NEUROIMMUNOL

SN - 2332-7812

IS - 4

ER -